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Abstract 
OBJECTIVES: To evaluate the Immunomodulatory, apoptosis induction and antitumor effects of aqueous and 
methanolic extracts of Calvatia craniiformis regarding the size of tumour mass, caspase-8 expression and 
apoptotic index (AI%) in mice transfected with murine hepatocellular carcinoma cell line (H22) as an experimental 
therapeutic system for human hepatocellular carcinoma. 
MATERIAL AND METHODS: Forty-eight Balb/C albino mice were transfected in legs with H22 cells. Tumour size 
was measured twice a week. Caspase-8 protein expression and apoptotic index determination evaluated by 
Immunohistochemistry. 
RESULTS: Tumor size significantly differed between the two groups of mice transfected with H22 cells; the first 
was treated with C. craniiformis aqueous extract (0.3, 0.6, 1.2) mg/kg and the second group was treated with C. 
craniiformis methanolic extract (0.25, 0.5, 1.0) mg/kg compared with control group. The inhibitory activity of 
aqueous and methanolic extracts was dose and duration dependent. The size of the tumour mass was reduced 
up to 87.9% when treated with 1.2 mg/kg aqueous extract and 1 mg/kg for methanolic extract. Caspase-8 
expression was increased in a dose-dependent manner among H22 bearing mice treated with C. craniiformis 
aqueous extract (0.3, 0.6, 1.2) mg/kg. At 0.3 mg/kg, the intensity of expression was strong in (33.33%) and very 
strong in (66.67%). While at 0.6 mg/kg and 1.2 mg/kg the intensity of expression was strong in (33.33%) and very 
strong in (100%) with a significant difference (P ≤ 0.001). H22 bearing mice treated with (0.25, 0.5, 1.0) mg/kg C. 
craniiformis methanolic extract shows increased caspase-8 expression in a dose-dependent manner. At 0.25 
mg/kg, the intensity of expression was strong in (33.33%) and very strong in (66.67%). While at 0.5 mg/kg, the 
intensity of expression was strong in (33.33%) and very strong in (100%). At 1.0 mg/kg, the intensity of expression 
was strong in (16.67%) and very strong in (83.33%) with significant difference (P ≤ 0.001). AI% of H22 bearing 
mice treated with C. craniiformis aqueous and methanolic extracts were significantly increased (P ≤ 0.05) 
compared with the untreated control group. No significant difference was reported in AI% between aqueous and 
methanolic extracts treated groups. 
CONCLUSIONS: Extracts of C. craniiformis were highly efficient in tumour growth inhibition, causing a reduction 
in the tumour size clinically and increase the expression of caspase-8 gene product in tumour tissue, causing 
increase apoptotic index of H22 cells taken from the legs of inoculated mice leading to loss of legs due to bone 
necrosis. Antitumor activity of C. craniiformis aqueous, and the methanolic extract was dose and duration 
dependent. 
 
 
 
Introduction 
 
The first written records on medicinal 
applications of plants date back to 2600 BC and report 
the existence of a sophisticated medicinal system in 
Mesopotamia, comprising about 1000 plant-derived 
medicines [1]. The Arabs preserved a large amount of 
the Greco-Roman knowledge during the dark and 
middle ages (i.e., 5th to 12th centuries), and 
complemented it with their medicinal expertise, and 
with herbs from Chinese and Indian traditional 
medicines [2].  
Cellular compounds and the secondary 
metabolites extracted from edible mushrooms can be 
used for the treatment of cancer by acting as a 
 Jameel et al. Immunomodulatory, Apoptosis Induction and Antitumor Activities of Extract of Calvatia Craniiformis 
_______________________________________________________________________________________________________________________________ 
_______________________________________________________________________________________________________________________________ 
Open Access Maced J Med Sci. 2018 Jul 20; 6(7):1206-1214.                                                                                                                                                   1207 
 
biological response modifier (BRM) [3]. BRM are 
immunostimulants which can be helpful in treating 
cancer (where targeted therapy often relies on the 
immune system being used to attack tumour cells) [4]. 
One of BRM, Maitake β-glucans called Grifolan, a 
branched β-1,3-d-glucan extracted from Grifola 
frondosa was found to promote tumour regression and 
necrosis and was approved to be used as anticancer 
therapy [5]. Aqueous extracts from Shiitake and 
Maitake, edible mushrooms showed increased host-
mediated antitumor activity against Sarcoma 180 
cancer [3]. Lentinan, a protein-free polysaccharide (β-
1,3-d-glucans and β-1,6-d-glucans) derived from the 
fruit body of Shiitake was approved for the treatment 
of gastric cancer in Japan. Lentinan was found to be 
instrumental in activating macrophages to stimulate 
lymphocytes and other immune cell defences like 
increasing natural Killer cells [3]. 
The biological characteristics of Calvatia 
craniiformis extracts were studied extensively, as 
some of their compounds showed medical benefits 
because they contain active ingredients such as 
Calvatic acid, which has anti-inflammation and a 
definite antitumor effect. C. craniiformis significantly 
inhibits the growth of Yoshida sarcoma in cell culture 
and increase the survival time of mice with leukaemia 
1210 [6]. Subsequent investigations have focused on 
the antitumor properties of calvatic acid, which may 
represent a model for the synthesis of more specific 
glutathione transferase-P1-1 inhibitors with possible 
therapeutic relevance [7]. 
The CASP8 gene encodes a member of the 
cysteine-aspartic acid protease (caspase) family. 
Sequential activation of caspases plays a central role 
in the execution-phase of cell apoptosis. Caspases 
exist as inactive proenzymes composed of 
a prodomain, a large protease subunit and a small 
protease subunit [8]. Activation of caspases requires 
proteolytic processing at conserved internal aspartic 
residues to generate a heterodimeric enzyme 
consisting of the large and small subunits [9]. This 
protein is involved in the programmed cell 
death induced by Fas and various apoptotic stimuli 
[10]. The N-terminal FADD-like death effector domain 
of this protein suggests that it may interact with Fas-
interacting protein FADD [9] [11]. 
Biochemically, caspase-8 was found to enter 
the complex of the inhibitor of NF-KB kinase (IKK) 
with the upstream Bcl10-MALT1 (mucosa-associated 
lymphatic tissue) adapter complex which was crucial 
for the induction of nuclear translocation of NF-κB 
[12]. Moreover, the biochemical form of caspase-8 
differed in the two pathways. For the death pathway, 
the caspase-8 zymogen is cleaved into subunits that 
assemble to form the mature, highly active caspase 
heterotetramer whereas, for the activation pathway, 
the zymogen appears to remain intact perhaps to limit 
its proteolytic function but enhance its capability as an 
adapter protein [13].  
The aim of the present study was to evaluate 
the Immunomodulatory, apoptosis induction and 
antitumor effects of aqueous and methanolic extracts 
of Calvatia craniiformis regarding the size of tumor 
mass, caspase-8 expression and apoptotic index 
(AI%) in mice transfected with murine hepatocellular 
carcinoma cell line (H22) as therapeutic experimental 
system for human hepatocellular carcinoma. 
 
 
Materials and Methods 
 
C. craniiformis obtained from groves of Al-
Khalis region - Diyala province, Iraq. The classification 
of mushroom achieved in fungi research laboratory, 
Faculty of Agriculture, University of Baghdad, Iraq by 
professor Salman Kamel Jabr. C. craniiformis belongs 
to the fungal kingdom Mycota, Class Agaricomycetes, 
family Lycoperdaceae. Figure 1-A represents the form 
of fungus discovered in Iraq by our team, and Figure 
1-B represents the cross-section with clearly 
appeared brown colour region filled with spores, which 
is part of the active ingredients used in the treatment. 
 
Figure 1:  The discovered Calvatia craniiformis forms; A) C. 
craniiformis in the grove; B) Cross-section of C. craniiformis in 
laboratory 
 
Fifty gram of soft plant was added to 500 ml 
of distilled water and then blended for 5-10 minutes 
until homogeneity. The extract was vibrated for an 
hour by shaker and then centrifuged for 10 minutes 
(2000 rpm/min). The sediment was discarded, and the 
supernatant was distributed in the clean, dry dishes 
and placed in an incubator for obtaining of the dry 
extract [14]. C. craniiformis crude aqueous extract 
gave 5 gm out of 75 grams of dry material, i.e. the 
extraction ratio was 6.66 % of crude C. craniiformis. 
The extract was dark brown to black colour, thick and 
little viscous. 
Twenty gram of dry powder was taken and 
placed in a thimble. The thimble was placed in the 
Soxhlet device where the solvent, hexane was added 
to remove fat and chlorophyll. The extraction was 
conducted for 12 hours at a temperature (40-60
o
C) for 
evaporation of solvent used. The obtained powder 
was transferred to the Reflex device with 70% 
methanol for three hours. The extract was filtered by a 
piece of gauze and filter paper then incubated for 24 
hours for evaporation of methanol.  
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Methanolic extract was treated with HCl 1% in 
a Reflex for 30 minutes and filtrated by Whatman 1 
filter paper. Diethyl ether was added to the filtrate in 
separating funnel and left for 24 hours. Two layers 
appeared, the top layer is the diethyl ether layer which 
had been neglected, and the bottom layer is an 
aqueous layer which picked. PH of the aqueous layer 
was raise for PH 8 by adding ammonia. Then after the 
aqueous extract was incubated to remove chloroform, 
the final form of the extract was obtained [15]. 
Methanolic extract gave 5 gm of 50 g, i.e. extraction 
ratio was 10% of the raw material. The resulting 
extract have yellowish-brown colour, thick and little 
viscous  
To determine any possible toxic effects for C. 
craniiformis, Up-and down method was followed for 
determination LD50 according to the following 
equation [16]: 
  
Xf: the last dose administered  
d: difference between dose levels 
k: tabular value calculated from Table (1). 
Table 1: the median lethal dose of alcohol and aqueous extract 
 
Type of 
Extract 
Difference 
between dose 
levels (d) 
Death of the 
animal or to 
stay alive 
after 24 
hours 
The value 
of K tabular 
The last dose 
administered 
(Xf) 
Midterm 
lethal dose 
(LD50) 
Aqueous 25 Ooxo -439 100 85 mg\kg 
Methanolic 50 Oxxx 1.5 200 177 mg\kg 
O: the survival animal within 24 hours of injection; X: the death of the animal within 24 
hours of injection. 
 
According to acute toxicity study, aqueous 
extract was administered in the following doses: 0.3 
mg/kg, 0.6 mg/kg, 1.2 mg/kg. Methanolic extract was 
administered in the following doses: 0.25 mg/kg, 0.5 
mg/kg, 1 mg/kg. 
Forty-eight albino Bclb/C mice (weight 18-20 
g) were purchased from Drug investigation 
department-ministry of health (Baghdad, Iraq). The 
mice were housed under normal condition and with 
free access to food and water. Animal experiments 
and animal care carried out according to protocols 
approved by the institutional committee for animal 
care and by the recommendation for the proper use 
and care of laboratory animals. Mice were divided into 
four groups, (6) mice for each one. Three groups 
received extract and one group for control receiving 
Dimethyl sulphoxide (DMSO).  
Murine Hepatocellular carcinoma cells (H22) 
was received from Tongji Hospital in Tonji University, 
Joaqon Hughoin (China). The steps for implant tissue 
carried out under sterile conditions. RPMI (1640) 
medium used for cultivation of H22 hepatocellular 
carcinoma cell line and development of full growth 
[17].  
After complete growth, H22 cells were 
harvested from RPMI 1640 Medium, and 0.1 ml of 
cells were transfected in the leg of (48) Balb/C albino 
mice to establish a solid tumour model [18]. The 
experiment ending with the death of the last mouse 
from the control group given doses of aqueous and 
methanolic extract. Tumour size was measured twice 
a week during the duration of the experiment using 
special calibre and take the measurement analogy 
(latitude and longitude), and extracted tumour size 
[19] [20]. 
Immunohistochemistry (IHC) used for 
evaluation of apoptosis. The procedure of IHC was 
performed according to the manufacturer’s instruction, 
using polyclonal rabbit anti-mouse caspase-8 IgG, 
ab25901 recognises the p18 form of Caspase-8 [21]. 
Secondary antibodies, Biotinylated goat anti-rabbit 
IgG. Final results visualised by using 
Immunohistochemistry detection kit, Expose Mouse 
and Rabbit Specific HRP/DAB Detection IHC kit 
ab80436 [22] 
The primary antibody diluted by the common 
antibody diluent 1:50. Optimal antibodies 
concentration may vary depending on specimen and 
preparation method. This optimisation has been done. 
Both positive and negative controls were included for 
each run of caspase-8 detection by IHC. The negative 
control was obtained by replacing the primary 
antibody with PBS buffer. The positive control was 
obtained by using tonsil tissue [23].  
The expression of the caspase-8 protein was 
measured by counting the number of positive cells 
with brown (DAB) nuclear staining under light 
microscopy X40. For the evaluation of caspase-8 
expression, immunostaining was assessed 
semiquantitatively using a scoring system for both 
intensity and extent of staining in 10 microscopic fields 
which were randomly selected and based on the 
estimated percentage of caspase-8 positive cells, 
staining results were divided into 5 scores , (0 = no 
expression, no positive cells; 1 = weak expression, 
less than 40% positive; 2 = moderate expression, 40-
60% positive cells; 3 = strong expression , more than 
60% but less than 100% positive cells; 4 = strong 
high
, 
100% positive cells) [24]. Final results for the 
apoptotic index were expressed as Mean ± SE [25] 
[26]. Apoptotic index % was determined according to 
the following equation [27]:  
 
Statistical analysis was performed using 
SPSS version 16 software. One-way Analysis of 
Variance (ANOVA), used to find out the significance of 
differences in caspase-8 expression; AI % between 
groups that composed of continuous variables. Mann-
Whitney test used to find out the difference between 
aqueous and methanolic extract AI% activity. The 
level of Significance at (P < 0.05) and (P < 0.01). 
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Results 
 
As shown in Figure 2, Administration of 
aqueous extract of C. craniiformis in 0.3 mg/kg, 0.6 
mg/kg, 1.2 mg/kg to H22 tumour-bearing mice shows 
significant differences (P ≤ 0.01) in tumour size 
compared with control group. Among given doses, 1.2 
mg/kg was effective dose causing a reduction in 
tumour size in last day of the experiment (36
th
), in 
which tumour size was 960 mm
3
 compared with 
1564.57 mm
3 
for 0.6 mg/kg and 3559.20 mm
3 
for 0.3 
mg/kg while in the control group the tumour size was 
5747.05 mm
3
. 
 
Figure 2: Tumor size follow up in mice transfected with H22 murine 
tumor cells treated with aqueous extract of C craniiformis; 
Significant difference in tumor size (p-value < 0.01) in the leg of 
inoculated mouse compared with H22 bearing mouse in control 
group that loss the legs inoculated with H22 Cells due to necrosis in 
the bones 
 
Administration of methanolic extract of C. 
craniiformis in 0.25 mg/kg, 0.5 mg/kg, 1 mg/kg to H22 
tumour-bearing mice shows a significant difference (P 
≤ 0.01) in tumour size compared with control group. A 
significant difference in tumour size throughout 
experiment was reported. Tumour size was increased 
slightly in the treated group compared with control. In 
last day of the experiment (36
th
), tumour size was 
1167.20 mm
3
 in the group treated with 1 mg/kg 
compared with 1332.64 mm
3 
for 0.5 mg/kg and 
2076.33 mm
3 
for 0.25 mg/kg while in control group the 
tumour size was 7747.04 mm
3
 as shown Figure 3.  
 
Figure 3: Tumor size follow up in mice transfected with H22 cells 
treated with a methanolic extract of C. craniiformis; the Significant 
difference in tumour size (p-value < 0.01) of mouse inoculated legs 
compared with the H22 bearing mouse in control group that loss the 
legs inoculated with H22 Cells due to necrosis in the bones 
Among given doses, 1 mg/kg was effective 
dose causing reduction in tumor size in last day (36
th
), 
in which tumor size was 1167.28 mm
3
 compared with 
1332.64 mm
3 
for 0.5 mg/kg and 2076.33 mm
3 
for 0.25 
mg/kg while in the control group the tumor size was 
7747.05 mm
3
 as shown in Figure 3. Inhibitory activity 
of the aqueous and methanolic extract was dose and 
duration dependent. The extract of C. craniiformis was 
effective in reduction of H22 tumour size at dose 1.2 
mg/kg for aqueous extract and 1 mg/kg for methanolic 
in which H22 tumour mass was reduced in size for up 
to 87.9% mg/kg as shown in Figure 2 and 3. 
Figure 4-B shown that H22 bearing mice 
treated with C. craniiformis aqueous extract using 
three consecutive doses (0.3, 0.6, 1.2) mg/kg shows 
significant inhibition of a tumour in the leg of the 
mouse compared with the H22 bearing mouse in 
control group that loss the legs inoculated with H22 
Cells due to necrosis in the bones.  
Table 2: The effect of C. craniiformis extracts on the apoptotic 
index of H22 bearing mice 
Type of Extract Dose (mg/kg) 
Apoptosis 
index   % 
ANOVA (P-value) 
Aqueous Extract 
Untreated Control 
group 
19.32 
P ≤ 0.05 0.3 25.34 
0.6 26.70 
1.2 27.21 
Methanolic Extract 
Untreated Control 
group 
18.30 
P ≤ 0.05 0.25 24.53 
0.5 25.06 
1 28.16 
 Mann-Whitney  test  
          (p-value ) 
P > 0.05  
 
As shown in Table 2 and Figure 5-A, H22 
bearing mice treated with C. craniiformis aqueous 
extract using three consecutive doses (0.3, 0.6 ,1.2) 
mg/kg shows a significant increase (P ≤ 0.05) in 
caspase-8 expression and hence in apoptotic index % 
(27.21%, 26.70%, 25.34%) compared with untreated 
control group (19.32%). 
 
Figure 4: Effect of aqueous and Methanolic extracts of C 
carniiformis on H22 tumor development in the legs of inoculated 
mice; A) control group inoculated with H22  cells  (Left), losing of 
leg due to bone necrosis and increased tumor size, compared with  
normal  uninoculated mouse (right), increased tumor size, leading 
to loss of leg due to bone necrosis and destruction; B) H22 cells  
bearing mouse treated with aqueous extract of C carniiformis, 
shows inhibition of the tumor  growth (right arrow)  compared with  
untreated control group inoculated with H22, increased tumor size, 
(left) leading to loss of leg due to bone necrosis and destruction; C) 
H22 cells  bearing mouse treated with methanolic  extract of C 
carniiformis, mouse  shows inhibition of tumor size  (left arrow)  
compared with untreated H22 inoculated mouse (right) 
 
Figure 4-C shown that H22 bearing mice 
treated with C. craniiformis methanolic extract using 
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three consecutive doses (0.25, 0.5, 1.0) mg/kg shows 
significant inhibition of a tumour in the leg of the 
mouse compared with the H22 bearing mouse in 
control group that loss the leg inoculated with H22 
Cells due to necrosis in the bones. As shown in Table 
2 and Figure 5-B H22 bearing mice treated with C. 
craniiformis methanolic extract (0.25, 0.5, 1.0) mg/kg 
shows significant increase (P ≤ 0.05) in the caspase-8 
expression and AI% (28.16%, 25.06%, 24.53%) 
compared with control group (18.30 %). No significant 
difference was reported in AI% between aqueous and 
methanolic extracts treated groups.  
 
Figure 5: Immunohistochemical staining tissue sections from the leg 
of H22 murine hepatocellular carcinoma bearing mouse show 
cellular expression of caspase-8. 5-A: Tissue sections from the leg 
of an H22 bearing mouse treated with a crude aqueous extract of C. 
craniiformis.  Up to 40% Cells with positive staining of caspase-8 
expression stained with DAB chromogen (dark brown) 
counterstained with Mayer’s hematoxylin (400X). 5-B: Tissue 
sections from the leg of an H22 bearing mouse treated with a crude 
methanolic extract of C craniiformis.  Up to 100% of Cells with 
positive caspase-8 expression stained with DAB chromogen (dark 
brown) counterstained with Mayer’s hematoxylin (400X). 5-C:  
untreated H22 hepatocellular carcinoma (control group). 
 
 
As shown in Table 3, H22 bearing mice 
treated with C. craniiformis aqueous extract using 
three consecutive doses (0.3, 0.6, 1.2) mg/kg show 
increase in caspase-8 expression in a dose-
dependent manner. At 0.3 mg, the intensity of 
expression was strong in (33.33%) and very strong in 
(66.67%). While at 0.6 mg and 1.2 mg the intensity of 
expression was strong in (33.33%) and very strong in 
(100%).  
Table 3: Effect of C. craniiformis extracts on the caspase-8 
expression of H22 bearing mice 
Caspase-8 
mRNA  
Expression 
Score 
Control group 
H22 Bearing mice treated with          
C. Craniiformis aqueous extract 
H22 Bearing mice treated with                               
C. Craniiformis  methanolic extract 
0.3mg 0.6mg 1.2mg 0.25 mg 0.5 mg 1 mg 
0 
1 (16.67%) 0   (0%) 0   (0%) 0   (0%) 0   (0%) 0   (0%) 0   (0%) 
1 3 (50%) 0   (0%) 0   (0%) 0   (0%) 0   (0%) 0   (0%) 0   (0%) 
2 2 (33.33%) 0   (0%) 0   (0%) 0   (0%) 0   (0%) 0   (0%) 0   (0%) 
3 0 (0%) 2 (33.33%) 0   (0%) 0   (0%) 2 (33.33%) 4 (66.67%) 1 (16.67%) 
4 0 (0%) 4 (66.67%) 6 (100%) 6 (100%) 4 (66.67%) 2 (33.33%) 5 (83.33%) 
Total No.(%) of 
Mice 
6 (100%) 6 (100%) 6 (100%) 6 (100%) 6 (100%) 6 (100%) 6 (100%) 
P value < 0.001 < 0.001 
 
 
A significant difference (P ≤ 0.001) in 
caspase-8 expression was reported. In H22 bearing 
mice treated with C. craniiformis methanolic extract 
using three consecutive doses (0.25, 0.5, 1.0) mg/kg 
show increase in caspase-8 expression in a dose-
dependent manner. At 0.25 mg, the intensity of 
expression was strong in (33.33%) and very strong in 
(66.67%). While at 0.5 mg, the intensity of expression 
was strong in (33.33%) and very strong in (100%). At 
1 mg, the intensity of expression was strong in 
(16.67%) and very strong in (83.33%). A significant 
difference (P ≤ 0.001) in caspase-8 expression was 
reported.  
 
 
Discussion 
 
The intake of mushrooms proved to be 
effective in cancer prevention, tumour growth 
inhibition and has high anti-tumour activity and a 
prevent tumour metastasis due to the high content of 
antioxidants thus, several mushrooms derived 
compounds are now increasingly used as an adjuvant 
to standard radio and chemotherapy [28] [29].  
In current study, administration of aqueous 
(0.3 mg/kg, 0.6 mg/kg, 1.2 mg/kg) and methanolic 
extracts (0.25 mg/kg, 0.5 mg/kg, 1 mg/kg) of C. 
craniiformis to H22 tumor-bearing mice show 
significant differences (P ≤ 0.01) in tumor size 
compared with control group in a dose and duration-
dependent manner. Among given doses, 1 mg/kg of 
methanolic extract was effective dose causing a 
reduction in tumour size in the last day (36
th
), tumour 
size was 1167.28 mm
3
 compared with 7747.05 mm
3
 
among the control group. This comes in line with [28], 
stated that as mushrooms contain different bioactive 
polyphenolic compounds, it effective in tumour growth 
inhibition and tumour metastasis. These compounds 
act as effective antioxidants based on their excellent 
ability to scavenge free radicals and act as reducing 
agents based on their high polyphenolic and 
ergosterol contents [30]. It was claimed that the 
puffball antioxidant capacity attributed to the presence 
of various chemicals such as ascorbic acid, 
carotenoids, esterified phenolics, and free and 
nonflavonoid phenolics and flavonoids [30] as well as 
ergosterol such as ergosterol ester, gallic, 
homogentisic, protocatechuic, p-hydroxybenzoic, 
and o- and p-coumaric acids, and other phenolic 
derivatives such as 3,4-dihydroxybenzaldehyde, 
ergothioneine, alkaloids, steroids, terpenoids [31] and 
selenium which protect cells from damage that might 
lead to chronic diseases and help to strengthen the 
immune system, as well [32] [33].  
The aqueous extract of C. craniiformis was 
effective in reduction of H22 tumour size at dose 1.2 
mg/kg and 1 mg/kg for methanolic in which H22 
tumour mass was reduced in size for up to 87.9% 
mg/kg. The reduction in tumour size proves the 
presence of a restriction in the tumour growth, 
angiogenesis inhibition and apoptosis induction as 
well as an increase in activity of the Immune system 
for fighting against cancerous cells. This comes in line 
with the fact that β-D-glucans which is one of 
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important constituent of C. craniiformis can inhibit 
tumour growth through inhibition of DNA polymerase 
and have the ability to modify Oncoprotein gene 
expression [34]. β-D-glucans, a protein-bound 
polysaccharide compound binds via specific receptors 
expressed as surface markers on phagocytic cells 
also play a vital role in stimulation and activation of 
phagocytic cells to invade tumour mass and stating 
destructive effects [35]. β-glucan caused direct 
enhancement of the colony-forming units 
granulocytes/macrophages (CFU-GM) response of 
bone marrow cells progenitors. Mushrooms are 
containing more than one polysaccharide with 
antitumor activity. The responses to different 
polysaccharides are likely to be mediated by different 
cell surface receptors, which may be present only on 
specific subsets of cells and may trigger distinct 
downstream responses. A combination of such 
responses involving different cell subsets could 
conceivably provide greater tumour inhibition that 
could be induced by a single polysaccharide [36]. A 
protein bound polysaccharide stimulates the functional 
maturation of macrophages and can scavenge active 
oxygen species which is widely prescribed for cancers 
of digestive organs like stomach, oesophagus colon 
etc. [37].  
H22 bearing mice treated with C craniiformis 
aqueous extract (0.3, 0.6, 1.2) mg/kg shows 
significant increase in caspase-8 expression and 
hence in apoptotic index % (27.21%, 26.70%, 
25.34%) compared with untreated control group 
(19.32%). H22 bearing mice treated with C. 
craniiformis methanolic extract (0.25, 0.5, 1.0) mg/kg 
shows significant increase in the caspase-8 
expression and apoptotic index % (28.16%, 25.06, 
24.53%) compared with control group (18.30%). 
The increase of AI% in H22 bearing mice 
indicate cytotoxic effects of C. craniiformis on tumour 
cells. This cytotoxic effects started by induction of the 
apoptotic process. Apoptosis can be induced via two 
different pathways. The extrinsic pathway is triggered 
by the ligation of death receptors such as CD95 and 
recruiting of caspase-8 to the death-inducing 
signalling complex [24]. 
The intrinsic pathway is initiated by the 
release of cytochrome c from the mitochondria, which 
interacts with apoptosis protease activating factor-1 
(APAF-1), caspase-9 and deoxyadenosine 
triphosphate to form the apoptosome complex. Links 
between the death receptor and the mitochondrial 
pathway exist at different levels [38].  
One of the possible pathways in H22 tumour 
inhibition is the activation of tumour necrosis factor-
related apoptosis-inducing ligand (TRAIL) which is a 
cytokine that is produced and secreted by most 
normal tissue cells. TRAIL plays a critical role in the 
NK cell-mediated and IFN-γ-dependent suppression 
of subcutaneous growth of TRAIL-sensitive tumours 
[10] [39]. TRAIL selectively induces apoptosis in 
cancer cells while normal cells are refractory [40]. 
TRAIL binds to Death Receptor (DR)-4 or -5 
expressed on the plasma membrane of tumor cells 
,resulting in recruitment of adapter molecules, Fas-
Associated Death Domain (FADD), Procaspase-8 and 
10 to the intracellular death domain (DD) of both 
receptors DR4 and DR5 [41] forming Death Inducing 
Signal Complex (DISC) [42]. This recruitment and 
clustering results in procaspase-8 dimerisation, 
activation, processing and release of active caspase-8 
from the complex. Caspase-8, then, activates 
downstream the effector caspases including 
procaspase-3, -6, and -7, leading to activation of 
specific kinases resulting in classical apoptotic cell 
death [43]. DR4 and DR5 expression on cancer cells 
have been suggested be one reason for TRAIL's 
selective anti-tumour properties [44].  
C. craniiformis lectins play a vital role in the 
inhibition of tumour growth. β-D-glucans which is one 
of the important constituents of C. craniiformis can 
inhibit tumour growth through inhibition of DNA 
polymerase and have the ability to modify 
Oncoprotein gene expression [34]. β-D-glucans, a 
protein-bound polysaccharide compound binds via 
specific receptors expressed as surface markers on 
phagocytic cells also play a vital role in stimulation 
and activation of phagocytic cells to invade tumour 
mass and stating destructive effects [35]. β-glucan 
caused direct enhancement of the colony-forming 
units granulocytes/macrophages (CFU-GM) response 
of bone marrow cells progenitors and activated the 
alternative complement pathway [45]. Antitumor β-
glucan induced the release of IL-1, IL-6 and TNF-α 
from macrophages [46]. 
Mushrooms are containing more than one 
polysaccharide with antitumor activity. The responses 
to different polysaccharides are mediated by different 
cell surface receptors, which may be present only on 
specific subsets of cells and may trigger distinct 
downstream responses. A combination of such 
responses involving different cell subsets could 
conceivably provide greater tumour inhibition that 
could be induced by a single polysaccharide [36]. A 
protein bound polysaccharide extracted from the 
mushroom displays various unique biological activities 
including the stimulation of functional maturation of 
macrophages and have an ability to scavenge active 
oxygen species which is widely prescribed for cancers 
of digestive organs like stomach, oesophagus colon 
and others [37]. The puffball Calvatia candida 
contains alkaloids, steroids and terpenoids, and have 
potent antioxidant activities [31]. C. craniiformis 
contain different bioactive polyphenolic contents and 
ergosterol compounds, ascorbic acid, carotenoids, 
esterified phenolics, and nonflavonoid phenolics and 
flavonoids [30]. These compounds act as effective 
antioxidants based on their excellent ability to 
scavenge free radicals and act as reducing agents. 
Different types of bioactive organic compounds 
showing antioxidant activities were isolated 
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from Tuber spp. These include ergosterol such as 
ergosterol ester, a wide range of phenolic acids such 
as gallic, homogentisic, protocatechuic, p-
hydroxybenzoic, and o- and p-coumaric acids, and 
other phenolic derivatives such as 3,4-
dihydroxybenzaldehyde. Mushrooms are the leading 
source of the essential antioxidant selenium, which 
protects cells from damage that might lead to chronic 
diseases and help to strengthen the immune system, 
as well [32]. Ergothioneine which is one of important 
constituent of C. craniiformis can protect cells from 
distraction via antioxidant activity [47], in contrast to 
lectins which have inhibitory effects on the mitotic 
activity of tumour cells [14] [34]. Gallic acid, containing 
C. craniiformis which is one of the types of phenols, 
as well as a longer parts tannin,  appears to works as 
an antioxidant that helps in protecting human cells 
from damage caused by oxidative stress processes 
[48]. Glucooligosacharide present in C. craniiformis 
have anticancer therapeutic effects due to its 
activation for T lymphocytes, NK cells and phagocytic 
cells leading to increase in production of TNF- and 
increase macrophages cytotoxicity against tumour 
cells via perforin-granzyme system [15] [34] [49] [50]. 
Although, no significant difference was 
reported in AI% between aqueous and methanolic 
extracts treated groups, the increased expression of 
caspase-8 leads to increased AI% and reduction in 
tumour size in dose and duration-dependent manner. 
This primarily due to the effect of antioxidant and 
inhibitory compounds found in C. craniiformis which 
triggered the apoptotic signals in tumour cells after 
binding with tumour cells such as Lectins, 
Ergothioneine, β-glucan, Glucooligosacharide which 
are main chemicals appeared after conducting 
chemical analysis of the components of the head 
fruiting of C. craniiformis by our team. Some of these 
compounds have hematopoietic and 
immunomodulatory activities which bringing the 
importance of its use in vivo, particularly in 
experimental animals as the use of these component 
led to inhibition of cancerous cells. Gallic acid which is 
one of C. craniiformis components have cytoprotective 
action and can maintain the cells from damage [48]. 
Several major substances with immunomodulatory 
and/or antitumor activity have been isolated from C. 
craniiformis. These include mainly polysaccharides (in 
particular β-D-glucans), polysaccharopeptides (PSP), 
polysaccharide proteins, and proteins. Furthermore, 
other bioactive substances, including triterpenes, 
lipids, and phenols, have been identified and 
characterised in mushrooms with proven medicinal 
properties.  
Polysaccharopeptides (PSP) present in C. 
craniiformis influence cancer metastasis in a number 
of ways: 1) by suppression of intravasation through 
the inhibition of tumor cells infiltration, 2) by 
suppression of tumor cell attachment to endothelial 
cells through the inhibition of tumor cell-induced 
platelet aggregation, 3) by suppression of tumor cell 
migration after extravasation through the inhibition of 
tumor cell mobility, and 4) by suppression of tumor 
growth after extravasation through the inhabitation of 
angiogenesis, the modulation of cytokine production 
and the augmentation of effector cell function [51] [52] 
and activation of alternative complement pathway 
[45]. 
As in another study on C. versicolor 
mushroom, the possible anti-tumor activity of C 
craniiformis may achieve due to various mechanisms 
mainly by Inhibition of DNA of tumor cells, 
Enhancement of cytokine production, antitumour 
activity in wide range of animal systems, Tumor cell 
killing effect, Inhibition of carcinogenesis, antioxidant 
effects, induction of apoptosis and antiproliferative 
effect; anti-invasion effects and anti-angiogenesis 
effects; tumouricidal and cytotoxicity effects; 
antimetastatic activity; Immunoprotective effects 
during radiation and chemotherapy [51]. 
 The major immunomodulating effects of 
active substances derived from mushrooms include 
mitogenicity and activation of immune cells, such as 
hematopoietic stem cells, lymphocytes, macrophages, 
dendritic cells (DCs) and natural killer (NK) cells, 
resulting in the increased production of cytokines, 
including interleukins (ILs) IL12, TNF-α; INF-γ and the 
ability to modulate the differentiation capacity of 
CD4+ T cells to mature into Th1 and/or Th2 subsets. 
Evidence indicates that mushrooms active substances 
induced TH differentiation toward Th1 more than Th2 
subset and induced most Th1-specific cytokines (IL-2, 
IFN-γ, and LT) and Th2-specific cytokine (IL-4) in 
tumour-bearing animals [45]. Thus regulated cytokine 
production and possessed both anti-tumour and 
immunopotentiating activities. The main mechanism 
might be an anti-teratogenic effect attributed to free 
radical trapping and prevention of chromosome injury, 
coupled to an immunomodulating effect linked to the 
modulation of cytokines production and effect cell 
function. 
The various experimental evidence 
demonstrated that the anti-tumour action of 
mushroom polysaccharides is due to the 
enhancement and potentiation of the cell-mediated 
immune system through the regulation of 
immunomodulatory cytokines and activation of the 
complement system and NK cells [53]. However, the 
mechanism of anti-tumour actions of PSP from most 
fungi is still not clear. It is accepted that anti-tumour 
polysaccharides enhance various immune responses, 
and act as biological response modifiers [53]. PSP is 
nonspecific immunopotentiators and exerts 
immunomodulatory actions by promoting the 
proliferation of T-lymphocytes, the activation of 
macrophages, NK cells, and Th cells, thereby 
inducing the production of antibody and interleukins 
[54] also has a favourable effect on the activation of 
leukocyte chemotactic locomotion and phagocytic 
activity [51]. 
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 The obvious effect of C. craniiformis is to 
stop the process of T lymphocytes apoptosis, a cells 
which responsible for fighting against viral infections 
who can dodge the immune system and also urged 
the liver cells to kill lymphocytes T effective, It was 
noted that the liver cells infected with HCV could urge 
or speed up the process of getting rid of activated T 
lymphocytes via apoptosis. Murine hepatocytes 
expressing a transgene encoding the HCV structural 
proteins core, envelope 1 (E1) and envelope 2 (E2) 
enhance the apoptosis of activated T cells. Unlike 
normal liver, which appears to remove only activated 
CD8+ T cells selectively, enhanced apoptosis 
determine for both CD4
+
 and CD8
+
 T cells via Fas–
FasL-dependent pathway [55] [56]. 
In conclusion, extracts of C. craniiformis were 
efficiently inhibited H22 tumour growth, leading to a 
reduction in the tumour size clinically and increase the 
expression of caspase-8 gene product in tumour 
tissue. This effect is causing an increase in the 
apoptotic index of H22 tumour cells taken from legs of 
inoculated animals, causing protection of H22 
inoculated legs from losing compared with an 
untreated control group which lost their legs due to 
necrosis and destruction in the bones. Antitumor 
activity of C. craniiformis aqueous and the methanolic 
extract was dose and duration dependent. These 
findings indicate the usefulness of C. craniiformis 
extracts as a novel antitumor agent for hepatocellular 
carcinoma, with its proved apoptosis induction through 
caspase-8 activation pathway.  
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